| Literature DB >> 35642706 |
M G Finco1, Suhhyun Kim1,2, Wayne Ngo2, Rachel A Menegaz1.
Abstract
Structural musculoskeletal adaptations following amputation, such as bone mineral density (BMD) or muscle architecture, are often overlooked despite their established contributions to gait rehabilitation and the development of adverse secondary physical conditions. The purpose of this review is to provide a summary of the existing literature investigating musculoskeletal adaptations in individuals with major lower-limb amputations to inform clinical practice and provide directions for future research. Google Scholar, PubMed, and Scopus were searched for original peer-reviewed studies that included individuals with transtibial or transfemoral amputations. Summary data of twenty-seven articles indicated reduced BMD and increased muscle atrophy in amputees compared to controls, and in the amputated limb compared to intact and control limbs. Specifically, BMD was reduced in T-scores and Z-scores, femoral neck, and proximal tibia. Muscle atrophy was evidenced by decreased thigh cross-sectional area, decreased quadriceps thickness, and increased amounts of thigh fat. Overall, amputees have impaired musculoskeletal health. Future studies should include dysvascular etiologies to address their effects on musculoskeletal health and functional mobility. Moreover, clinicians can use these findings to screen increased risks of adverse sequelae such as fractures, osteopenia/porosis, and muscular atrophy, as well as target specific rehabilitation exercises to reduce these risks.Entities:
Keywords: Anatomy; Limb Loss; Physiology; Remodeling; Symmetry
Mesh:
Year: 2022 PMID: 35642706 PMCID: PMC9186459
Source DB: PubMed Journal: J Musculoskelet Neuronal Interact ISSN: 1108-7161 Impact factor: 1.864
Figure 1Flow diagram of the inclusion process.
Summary of Included Studies
| Author, Year | Title | Participants With Amputation | Methods | Time Points | Comparison | |
|---|---|---|---|---|---|---|
|
| Bemben et al. (2017) | Acute bone changes after lower limb amputation resulting from traumatic injury | 8 TT; Mean age 35.4 (SD 11.1); All traumatic etiologies | DXA measured BMD for total body, lumbar spine, femoral neck, proximal femur; pQCT measured residual limb volumetric BMD, stress-strain index, and muscle cross-sectional area | Prior to prosthesis fitting; 6 months post-prosthesis; 12 months post-prosthesis; additional blood draw occurred at time of surgery | Amputated vs intact limbs; over time points |
| Cavedon et al. (2021) | Body composition and bone mineral density in athletes with a physical impairment | 18 total 7 TT and 11 TF Mean age 34.4; All athletes of at least two years in adaptive sports | DXA measured whole-body and regional: total mass, lean mass, fat mass, % fat mass, fat mass/lean mass, BMC, and BMD | Cross-sectional; inclusion stated all athletes of at least two years in adaptive sports | Amputated vs intact limbs; amputee group vs spinal cord injury group vs control group | |
| Haket et al. (2017) | Periprosthetic cortical bone remodeling in patients with an osseointegrated leg prosthesis | 27 TF with osseointegration; 21 males, 6 females Mean age 48 (range 23-68); Mean TSA 18 years (range 2-45) | DXA measured BMD at the femoral neck (DXA only included 24 patients); X-ray measured periprosthetic cortical thickness; | Immediately post-op; 1 year post-op; 2 years post-op | Amputated vs intact; time points | |
| Hansen et al. (2019) | Changes in periprosthetic bone mineral density and bone turnover markers after osseointegrated implant surgery: A cohort study of 20 transfemoral amputees with 30-month follow-up | 19 TF with osseointegration; 12 males, 7 females; Mean age 49 (SD 11.17) | DXA measured BMD in lumbar spine, proximal femur and seven periprosthetic regions (zones 1-7 may or may not be similar to other studies) | Pre-op (2-21 days before surgery), and 1, 3, 6, 7, 9, 12, 18, 24 and 30 months after the S1 surgery or until implant was removed | Amputees vs controls; removed OI implant over nonremoved OI implant; over time points | |
| Hoyt et al. (2021) | Femoral Neck Hounsfield Units as an Adjunct for Bone Mineral Density After Combat-Related Lower Extremity Amputation | 26 individuals with 30 amputations total; 17 TT amputations and 13 TF amputations; All males; Mean age 26.4 (range 22-29); All traumatic etiologies | DXA measured BMD at femoral neck; CT measured Hounsfield units at femoral neck | Cross-sectional; inclusion criteria stated DXA and CT scans within 6 months of each other; DXA scans taken 5-11 months post-injury (mean 6 months) | Correlation b/t hounsfield units from CT scans and BMD from DXA scans | |
| Ramírez et al. (2011) | Analysis of bone demineralization due to the use of exoprosthesis by comparing Young’s modulus of the femur in unilateral transfemoral amputees | 20 TF; 3 females and 17 males; Mean age 44.6 (range 23–71); Mean TSA 10.9 years; All used SACH foot and mechanical monocentric knee | CT measured Young’s Modulus (no BMD data presented- just correlations) | Cross-sectional; no inclusion criteria stated | Amputated vs intact proximal femur at three locations= femoral neck, metaphysis just below lesser trochanter, and proximal quarter of the diaphysis | |
| Royer and Koenig (2005) | Joint loading and bone mineral density in persons with unilateral, trans-tibial amputation | 9 TT; 8 male 1 female; Mean age 41.7 (SD 10.6); Mean TSA 16.7 years (STD 10.9); All used ESAR feet; 4 traumatic etiologies, 1 diabetic, 2 congenital, 1 blood clot, 1 infection; | DXA measured BMD in proximal femur and tibia | Cross-sectional | Amputated vs intact vs averaged matched control limb value | |
| Rush et al. (1994) | Osteopenia in patients with above knee amputation | 16 TF; All male; Mean age 48 range (23-66) All ischial weight bearing sockets; 9 suction sockets and 7 silesian belt suspension; 8 traumatic etiologies, 6 cancer, 2 vascular | DXA measured BMD for L2 and femoral neck | Cross-sectional; inclusion says prosthesis users for over 5 years | Amputated vs intact; amputee group vs controls | |
| Sherk et al. (2008) | BMD and bone geometry in transtibial and transfemoral amputees | 14 total; 7 TT (5 males and 2 females); Mean age 43.4 (SD 6.0); 7 TF (6 males and 1 female); Mean age 45.7 (SD 5.7); TSA (14.7 TT and 15.5 TF), and hours/day of prosthesis wear (15 TT and 11 TF); 11 traumatic etiologies, 1 secondary to diabetes, 1 secondary to circulation issues, and 1 secondary to osteomyelitis; both groups had similar numbers of years wearing a prosthesis (14.4 TT and 15.4 TF), | DXA measured areal BMD of the dual proximal femur, lumbar spine, and total body; pQCT measured volumetric BMD and bone geometry at the distal ends of both limbs | Cross-sectional; inclusion stated ambulatory with a prosthesis for at least 6 months | Amputated vs intact limbs; group comparisons for both levels and two groups of nonamputee controls (one transtibial control group and one transfemoral control group) | |
| Smith et al. (2009) | A study of bone mineral density in adults with disability | 52 lower-limb amputees (no further details) | DXA measured BMD for total lumbar spine, femoral neck, total proximal femur | Cross-sectional; inclusion stated they had to have their disability for at least 3 months | Amputees vs other groups with musculoskeletal deficits (e.g. spinal cord injury) | |
| Smith et al. (2011) | A study of BMD in lower limb amputees at a national prosthetics center | 52 total; 24 TT; 19 TF; 8 bilateral; 1 hip disarticulation; 39 males and 13 females Mean age 61.9 (SD 12.8) | DXA measured BMD in lumbar spine, femoral neck, and proximal femur | Cross-sectional | Amputated vs intact; male vs female | |
| Thomson et al. (2019A) | Proximal Bone Remodeling in Lower Limb Amputees Reconstructed With an Osseointegrated Prosthesis | 48 total with osseointegration; 15 TT (12 males and 3 females) and 33 TF (22 males and 11 females); Mean age 51 (SD 13.5); TF group split into 2 groups depending on presence of femoral neck lag screw | DXA measured BMD at lumbar spine and femoral neck | Pre-op; 1 year post-op; and 3 years post-op | Amputated vs intact limbs; between amputation level/femoral neck screw groups; over time points | |
| Thomson et al. (2019B) | Radiographic Evaluation of Bone Remodeling Around Osseointegration Implants Among Transfemoral Amputees | 28 TF with osseointegration; 15 received integral leg prosthesis (10 male and 5 female) and 13 received osseointegration prosthetic limb type A (8 male and 5 female); Mean age 48 years (SD 12.4) | X-rays measured bone density, longitudinal bone coverage, and bone width | About 6 months post-op (0.4 with STD of 0.5 years); about 3 years post-op(3.0 with STD of 0.8 years) | 7 femoral (inverse Gruen) zones; between osseointegration implant groups; over time points | |
| Tugcu et al. (2009) | Muscle strength and bone mineral density in mine victims with transtibial amputation | 15 TT; All male; Mean age 26.2 (SD 3.9); Mean TSA 57.9 months (SD 47.5) All traumatic etiologies; All PTB sockets | DXA measured BMD at femoral neck, Ward’s triangle, total femur, and total tibia | Cross-sectional | Amputated vs intact | |
| Yazicioglu et al. (2008) | Osteoporosis: A factor on residual limb pain in traumatic trans-tibial amputations | 36 TT; All male; Mean age 26.8 (SD 3.5); Mean TSA 62.8 months (SD 37); All traumatic etiologies | DXA measured BMD for femoral neck, Ward’s triangle, total hip, and proximal tibia | Cross-sectional | Amputated vs intact | |
|
| Bramley et al. (2021) | Changes in Tissue Composition and Load Response After Transtibial Amputation Indicate Biomechanical Adaptation | 10 TT; (6 males and 4 females); Mean age 41 (range 25-62); Mean TSA 7.5 years; 2 chronic regional pain disease etiologies, 2 congenital, 5 traumatic, 1 vascular; Mean daily socket use 12.5 hours (range 6-16) | MRI measured fatty infiltration of limbs | Cross-sectional | Amputated vs intact vs control |
| de Palma et al. (2011) | Involvement of the muscle-tendon junction in skeletal muscle atrophy: an ultrastructural study | 15 TT Group A= 12 elderly (mean age 79 years; range 65-85) 10 males and 2 females; 10 vascular etiologies, 1 osteomyelitis, 1 cancer Group B= 3 healthy young adults (mean age 32 range 25-35); All male; All traumatic etiologies | Histology measured fiber structures; EM measured base/perimeter ratio in musculotendinous junction | Cross-sectional | Group A vs B | |
| George et al. (2021) | Circumference Method Estimates Percent Body Fat in Males U.S. Service Members with Lower Limb Loss | 47 total; 23 unilateral TT; 4 bilateral TT; 14 unilateral TF; 3 bilateral TF; 3 TT/TF; Mean age 27.6 years (SD 5.7) | DXA measured percent body fat | Cross-sectional | Amputees vs controls | |
| Henson et al. (2021) | Understanding lower limb muscle volume adaptations to amputation | 12 total; 6 unilateral TT; mean age 33.7 years (SD 1.9); mean TSA 7.5 years 6 bilateral TF; mean age 31.8 years (SD 2.9); mean TSA 7.2 years; All male; All traumatic etiologies; All used dynamic response feet; All TF used MPKs | MRI measured gross skeletal measurements and muscle volume | Cross-sectional | Amputated vs intact (in TT) vs control | |
| Jaegers et al. (1995) | Changes in hip muscles after above-knee amputation | 12 TF; Mean age 38.2 (SD of 18); TSA 3- 35 years (mean 9.4); 7 traumatic etiology and 5 osteosarcomic etiology | MRI measured femur and muscle volume | Cross-sectional; inclusion said at least 2 years post-amputation | Amputated vs intact vs control | |
| Onat et al. (2016) | Ultrasonographic assessment of the quadriceps muscle and femoral cartilage in transtibial amputees using different prostheses | 38 TT; 13 using vacuum suspension; 11 male and 2 female; Mean age 41.9 years with SD 11.8; TSA 10.8 years; Prosthesis use 5.6 years); 25 using pin-lock suspension; 20 males and 5 females; Mean age 40.6 years with SD 11.6; Mean TSA 16.3 years; prosthesis use 6.6 years) | Ultrasound of femoral cartilage thickness (intercondylar area, lateral femoral condyle, medial femoral condyle) and quadriceps muscle thickness (rectus femoris, vastus intermedius, vastus intermedius, and vastus medialis) | cross-sectional; inclusion states at least 6 months of prosthesis use | Amputated vs intact limbs; two suspension groups | |
| Putz et al. (2017) | Structural changes in the thigh muscles following trans-femoral amputation | 12 TF; 6 males and 6 females; Mean age 44.1 at amputation (range 21-69); All cancer | MRI measured fatty infiltration and degeneration at the middle and distal end of specific muscles within the residual limb | About 1 year post-op (avg 10.6 months SD 12.6); about 2 years post-op (avg 25.6 months SD 21.4); 12 patients included at time 1 but only 7 patients included at time 2 | Middle vs end of residual limb; time points | |
| Renström et al. (1983) | Thigh muscle atrophy in below-knee amputees | 10 TT; 8 males and 2 females; Mean age 56; 4 vascular etiologies, 2 infection, 4 trauma; Mean TSA 24 months (SD 37) | Histology measured fast and slow-twitch fibers, fiber sizes, and fiber area; CT measured mean fiber area of muscles in the thigh; measuring tape determined cross-sectional area of the thigh | Cross-sectional | Amputated vs intact; type 1 vs 2 fibers | |
| Schmalz et al. (2001) | Selective thigh muscle atrophy in trans-tibial amputees: an ultrasonographic study. | 17 TT; 15 male and 2 female; Mean age 47 (SD 18); 14 traumatic etiologies, 1 due to infection, 1 due to tumor, and 1 due to venous thrombosis; All had patellar tendon bearing prostheses | Ultrasound measured cross-sectional area and thickness of the quadriceps femoris, sartorius, gracillis, semitendinosus, and biceps femoris | Cross-sectional; demographics state at least 6 months of prosthesis use (range 0.5 - 19 years with median of 5 years) | Amputated vs intact vs control limb | |
| Sharma et al. (2019) | Fast and slow myosin as markers of muscle regeneration in mangled extremities: a pilot study | 15 lower-limb amputees (no level details); All trauma | Histology measured fast and slow myosin in residual limb | During amputation surgery, at 7 day follow-up | Fast vs slow myosin; time points | |
| Sherk et al. (2010) | Interlimb muscle and fat comparisons in persons with lower-limb amputation | 12 total 7 TT; Mean age 43.4 (SD 15.8) 5 TF; Mean age 38.5 (SD 10.6) | DXA measured thigh and lower-leg fat mass and bone-free lean body mass; qQCT measured muscle cross-sectional areas and fat cross-sectional areas of the end of residual and intact limbs with thresholding technique to determine the composition of fat vs muscle | Cross-sectional; inclusion states ambulatory for at least 6 months | Amputated vs intact limbs; amputee vs control groups | |
| Sibley et al. (2020) | The effects of long-term muscle disuse on neuromuscular function in unilateral transtibial amputees | 9 TT; All male; Mean age 40.3 (SD 8.5); All traumatic etiologies | Ultrasound of the vastus lateralis measured muscle thickness, pennation angle, and fascicle length | Cross-sectional; inclusion states amputation performed at least 6 months prior | Amputated vs intact vs control |
Studies are categorized by skeletal or muscular methodologies. All individuals with amputation were unilaterally affected unless otherwise specified. Mean age is in years unless otherwise specified. Abbreviations: TT= transtibial, TF= transfemoral, SD= standard deviation, TSA = time since amputation, DXA= Dual Energy X-ray Absorptiometry, pQCT= peripheral quantitative computed tomography, BMD= bone mineral density, CT= computed tomography, MRI= magnetic resonance imaging, MPKs= microprocessor knees.
Summary of Mean Skeletal Data.
| Study | TT Group | TF Group | Amputee Group (level unspecified) | Control Group | TT Limb | Intact Limb | TF limb | Intact Limb | Amputated Limb (level unspecified) | Intact Limb | Control Limb | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
| |||||||||||
| Smith et al. (2011) | - | - | - | - | - | - | - | - | -1.91 male, - 2.63 female | -1.3 male, -1.96 female | - | |
| Tugcu et al. (2009) | - | - | - | - | -0.4 | 0.8 | - | - | - | - | - | |
| Yazicioglu et al. (2008) | - | - | - | - | -0.69 | 0.35 | - | - | - | - | - | |
|
| ||||||||||||
| Tugcu et al. (2009) | - | - | - | - | -0.5 | 1.1 | - | - | - | - | - | |
| Yazicioglu et al. (2008) | - | - | - | - | -0.88 | 0.59 | - | - | - | - | - | |
| Ward’s triangle | ||||||||||||
| Tugcu et al. (2009) | - | - | - | - | 0.3 | 1.5 | - | - | - | - | - | |
| Yazicioglu et al. (2008) | - | - | - | - | -0.12 | 0.84 | - | - | - | - | - | |
|
|
| |||||||||||
| Smith et al. (2011) | - | - | - | - | - | - | - | - | - | 0.11 male, 0.63 female | - | |
| Thomson et al. (2019A) | 0.466 | 0.19 without femoral lag screw, -0.3 with | 0.163 | - | - | - | - | - | - | - | - | |
|
| ||||||||||||
| Smith et al. (2011) | - | - | - | - | - | - | - | - | -0.38 male, 0.19 female | -1.01 male, -0.48 female | - | |
| Thomson et al. (2019A) | - | - | - | - | -0.32 | 0.4428 | -2.309 without femoral lag screw, -2.291 with | 0.0476 without femoral lag screw, 0.3273 with | - | - | - | |
|
|
| |||||||||||
| Bemben et al. (2017) | 1.271 pre, 1.279 6MO, 1.271 12MO | - | - | - | - | - | - | - | - | - | - | |
| Cavedon et al. (2021) | 1.2 | 1.15 | 1.17* | - | - | - | - | - | - | - | ||
| Sherk et al. (2008) | 1.272 | 1.227 | - | 1.275 for TT controls, 1.264 for TF controls | - | - | - | - | - | - | - | |
|
| ||||||||||||
| Bemben et al. (2017) | 1.266 pre, 1.244 6MO, 1.257 12MO | - | - | - | - | - | - | - | - | - | - | |
| Hansen et al. (2019) | - | 1.13 | - | 1.18 | - | - | - | - | - | - | - | |
| Sherk et al. (2008) | 1.296 | 1.241 | - | 1.336 for TT controls 1.441 for TF controls | - | - | - | - | - | - | - | |
| Smith et al. (2009) | - | - | 0.994 | - | - | - | - | - | - | - | - | |
| Smith et al. (2011) | - | - | 1.039 male, 0.865 female | - | - | - | - | - | - | - | - | |
| Thomson et al. (2019A) | 1.3164 | 1.268 without femoral lag screw 1.173 with femoral lag screw | 1.261 | - | - | - | - | - | - | - | - | |
|
| ||||||||||||
| Bemben et al. (2017) | - | - | - | - | 1.087 pre, 0.996 6MO, 0.984 12MO | 1.119 pre, 1.087 6MO, 1.095 12MO | - | - | - | - | - | |
| Haket et al. (2017) | - | - | - | - | - | - | 0.68 preop, 0.67 12MO, 0.69 24MO | - | - | - | ||
| Rush et al. (1994) | - | - | - | - | - | - | 0.68 | 1.01 | - | - | - | |
| Sherk et al. (2008) | - | - | - | - | 1.015 | 1.077 | 0.704 | 1.064 | - | - | 1.072 for TT, 1.146 for TF | |
| Smith et al. (2009) | - | - | 0.724 | - | - | - | - | - | - | - | ||
| Smith et al. (2011) | - | - | - | - | - | - | - | - | 0.672 male, 0.556 female | 0.753 male, 0.632 female | - | |
| Thomson et al. (2019A) | - | - | - | - | 0.9747 | 1.072 | 0.709 without femoral lag screw, 0.6725 with | 1.016 without femoral lag screw, 1.01 with | 0.783 | 1.031 | - | |
| Tugcu et al. (2009) | - | - | - | - | 1.01 | 1.55 | - | - | - | - | - | |
| Yazicioglu et al. (2008) | - | - | - | - | 0.97 | 1.11 | - | - | - | - | - | |
| Ward’s triangle | ||||||||||||
| Tugcu et al. (2009) | - | - | - | - | 0.99 | 1.15 | - | - | - | - | - | |
| Yazicioglu et al. (2008) | - | - | - | - | 0.94 | 1.06 | - | - | - | - | - | |
|
| ||||||||||||
| Bemben et al. (2017) | - | - | - | - | 0.862 pre, 0.734 6MO, 0.739 12MO | 0.904 pre, 0.911 6MO, 0.912 12MO | - | - | - | - | - | |
| Hansen et al. (2019) | - | - | - | - | - | - | 0.66 | 1.03 | - | - | 1.04 | |
| Royer and Koenig, (2005) | - | - | - | - | 0.82* | 0.94* | - | - | - | - | 0.92* | |
| Sherk et al. (2008) | - | - | - | - | 0.817 | 0.93 | 0.527 | 0.937 | - | - | 0.915 for TT, 0.904 for TF | |
| Smith et al. (2009) | - | - | 0.897 | - | - | - | - | - | - | - | - | |
| Smith et al. (2011) | - | - | - | - | - | - | - | - | 0.807 male, 0.617 female | 0.947 male, 0.738 female | - | |
|
| ||||||||||||
| Royer and Koenig, (2005) | - | - | - | - | 0.75* | 1.09* | - | - | - | - | 0.99* | |
| Tugcu et al. (2009) | - | - | - | - | 0.56 | 0.86 | - | - | - | - | - | |
| Yazicioglu et al. (2008) | - | - | - | - | 0.6 | 0.95 | - | - | - | - | - | |
|
|
| |||||||||||
| Bemben et al. (2017) | - | - | - | - | - | - | 701.1 pre, 564.9 6MO, 551.3 12MO | 788.3 pre, 722.1 6MO, 798.1 12MO | - | |||
| Sherk et al. (2008) | - | - | - | 512.3 | 757.3 | 462.7 | 812.3 | - | - | 749.7 for TT controls, 927.7 for TF controls | ||
Summary of skeletal data reported in at least two studies included in this review. Asterisk (*) indicates value was estimated from a graph. Dash (-) indicates data was not reported. Abbreviations: TT= transtibial, TF= transfemoral, BMD= bone mineral density, MO= months.
Summary of Mean Muscle and Fat Data.
| Study | TT Group | TF Group | Control Group | TT Limb | Intact Limb | TF Limb | Intact Limb | Amputated Limb (level unspecified) | Intact Limb | Control Limb | |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
| ||||||||||
| Bemben et al., (2017) | - | - | - | - | - | - | - | 6324.8 pre, 4117.8 6MO, 3554.7 12MO | 6479.1 pre, 69(20.5 6MO, 6515.5 12MO | - | |
| Renstrom et al., (1983) | - | - | - | 86% | - | - | - | - | - | - | |
| Sherk et al., (2010) | - | - | - | 1621.3mm2 | 5320.4mm2 | 4818.9mm2 | 17122.8mm2 | - | - | 5675.9 mm2 TT, 17,028.3 mm2 TF | |
|
| |||||||||||
| Jaegers et al., (1995) | - | - | - | 40.1% atrophy compared to intact | - | - | - | - | - | - | |
| Schmalz et al., (2001) | - | - | - | 88.30% | - | - | - | - | - | - | |
|
| |||||||||||
| Jaegers et al., (1995) | - | - | - | 24.6% atrophy compared to intact | - | - | - | - | - | - | |
| Schmalz et al., (2001) | - | - | - | 95.10% | - | - | - | - | - | - | |
|
| |||||||||||
| Jaegers et al., (1995) | - | - | - | 44.3% atrophy compared to intact | - | - | - | - | - | - | |
| Schmalz et al., (2001) | - | - | - | 91.90% | - | - | - | - | - | - | |
|
| |||||||||||
| Jaegers et al., (1995) | - | - | - | 32.9% atrophy compared to intact | - | - | - | - | - | - | |
| Schmalz et al., (2001) | - | - | - | 92.00% | - | - | - | - | - | - | |
|
|
| ||||||||||
| Onat et al., (2016) | - | - | - | 9.63mm | 11.06mm | - | - | - | - | - | |
| Schmalz et al., (2001) | - | - | - | 80.20% | - | - | - | - | - | - | |
| Sibley et al., (2020) | - | - | - | 15.4mm | 26.3mm | - | - | - | - | 25.0mm | |
|
| |||||||||||
| Onat et al., (2016) | - | - | - | 15.6mm | 17.63mm | - | - | - | - | - | |
| Schmalz et al., (2001) | - | - | - | 84.30% | - | - | - | - | - | - | |
|
| |||||||||||
| Onat et al., (2016) | - | - | - | 11.6mm | 17.04mm | - | - | - | - | - | |
| Schmalz et al., (2001) | - | - | - | 76.20% | - | - | - | - | - | - | |
|
| |||||||||||
| Onat et al., (2016) | - | - | - | 12.23mm | 16.66mm | - | - | - | - | - | |
| Schmalz et al., (2001) | - | - | - | 69.60% | - | - | - | - | - | - | |
|
|
| ||||||||||
| Cavedon et al., (2021) | 21.47 | 21.45 | 16* | - | - | - | - | - | - | - | |
| Sherk et al., (2010) | 33.5 | 32.4 | 24.2 TT controls 25.5 TF controls | - | - | - | - | - | - | - | |
| George et al., (2021) | uni 23.1; bi 23.1 | uni 23.4; bi 17.2 | 19.5 | ||||||||
|
| |||||||||||
| Cavedon et al., (2021) | 26.5 | 34.58 | - | - | - | - | - | - | - | - | |
| Sherk et al., (2010) | 38* | 42* | 30.0 TT controls, 29.0 TF controls* | - | - | - | - | - | - | - | |
|
| |||||||||||
| Cavedon et al., (2021) | 20.66 | 21.72 | - | - | - | - | - | - | - | - | |
| Sherk et al., (2010) | 36* | 33* | 30.5 TT controls, 28.5 TF controls* | - | - | - | - | - | - | - | |
Summary of muscle and fat data reported in at least two studies included in this review. Asterisk (*) indicates value was estimated from a graph. Dash (-) indicates data was not reported. Abbreviations: TT= transtibial, TF= transfemoral, uni= unilateral limb loss, bi= bilateral limb loss.